Ticker ARCT – Arcturus Therapeutics Holdings Inc – sales, description, marketcap – Tickerday.com

ARCT

Arcturus Therapeutics Holdings Inc

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 1.03B; Volume: 72.37K; AvgVol 3m: 775.57K; Beta: ;

Cost estimate:

P/E: ; EPS: -2.87; EPS growth quarter/prev quarter: -730.00%;

EPS growth this year: 0.50%; EPS growth past 5 years: 33.70%;

EPS ttm: -2.87;

P/S: 101.60; P/B: 9.49; P/Cashflow: ; P/FCF: ;

Sales: 11.26M; Sales growth quarter/prev quarter: -77.50%; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -39.30%; ROE – return on equity: -89.40%; LT Debt/Equity: 0.16; Total Debt/Equity: 0.16;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 22.40%; Insider Transactions:-0.25%;

Institutional Ownership: 52.90%; Institutional Transactions: 185.41%;

Data update: 07/10/2020.

Leave a comment

Your email address will not be published. Required fields are marked *